At a glance
Dialog® Solutions is a global information business unit owned and operated by ProQuest LLC, bringing together content, software and services under a single umbrella to make informed decisions and fuel discoveries based on authoritative content.
Dialog remains a powerful content platform offering an intuitive interface for both end users and information professionals including command line queries for powerful precision search. With over 140+ databases, 1.3 billion documents covering biomedical, engineering, dissertations, patents, news and business on a single platform we are able to serve key workflows for medical literature monitoring, innovation and prior art, competitive intelligence and evidence-based medicine. Our validated SaaS based solution, the Drug Safety Triager, seamlessly ingests Dialog alert results with an audit trail to support efficient, consistent and timely review of literature articles, while being developed, implemented and controlled in accordance to industry best practices, standards and regulations including, but not limited to, GAMP 5, ISO 9001:2015, EMA Good Pharmacovigilance Practices and FDA 21 CFR part 11/211/820. We also share our valuable expertise and experience through our dedicated services group providing alert and search strategy creation, maintenance and updating, as well as literature indexing and ICSR review services.
- Our company is part of the CIG group based in New York
- Dialog Solutions is part of the wider ProQuest family and you can find out all about them here
- ExLibris is a key part of the group and you can find out all about their company, products and services here
- Dialog Solutions’ acquired Pi2 and integrated the Drug Safety Triager, Literature Review Services and PinPoint products into its offer.